Cipla, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹1479.95. The stock has experienced fluctuations today, with a low of ...

Cipla Ltd. key Products/Revenue Segments include Pharmaceuticals, Royalty Income, Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Mar-2023.For the quarter ended 31-12-2024, ...

For this particular reason, we've rounded up 10 tablets over 12 inches that deliver in size and substance alike. There's a decent smatter of flagship tablets with excellent performance and ...

Cipla Ltd. is a Public Limited Listed company incorporated on 17/08/1935 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is ...

Lenovo Tab P12 Pro tablet was launched on 8th September 2021. The tablet comes with a 12.60-inch touchscreen display offering a resolution of 2560x1600 pixels. Lenovo Tab P12 Pro is powered by an octa ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

There are some great tablets that are priced under Rs. 20,000 in India, and this list shows you those models that are currently available in the country, with the latest launched tablet shown first.

Cipla Foundation, along with CanSupport, have expanded free palliative home care services in Pune. With nine dedicated home care teams, the initiative will provide supportive care to more than 900 ...

Cipla's protein-bound paclitaxel is a generic therapeutic equivalent version of Bristol Myers Squibb's Abraxane for injectable suspension 100 mg/vial.

Drug major Cipla on Friday said it has received approval from the US health regulator to market a generic cancer treatment drug. The company has received the final approval from the US Food and ...